Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 37% ± 5% |
Insufficient scRNA-seq data for expression of SLC6A12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 5262.84 | 89 / 89 | 97% | 34.50 | 874 / 901 |
brain | 100% | 2011.30 | 2639 / 2642 | 86% | 5.44 | 609 / 705 |
liver | 100% | 2948.22 | 225 / 226 | 85% | 22.31 | 344 / 406 |
thymus | 99% | 1265.17 | 646 / 653 | 81% | 10.67 | 493 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.41 | 1 / 1 |
ovary | 16% | 42.96 | 28 / 180 | 83% | 8.88 | 356 / 430 |
lung | 40% | 127.29 | 234 / 578 | 21% | 0.83 | 237 / 1155 |
pancreas | 38% | 171.83 | 123 / 328 | 22% | 0.86 | 39 / 178 |
uterus | 37% | 192.79 | 63 / 170 | 20% | 1.20 | 90 / 459 |
lymph node | 0% | 0 | 0 / 0 | 45% | 2.05 | 13 / 29 |
skin | 1% | 1.56 | 13 / 1809 | 32% | 1.61 | 149 / 472 |
peripheral blood | 29% | 154.36 | 274 / 929 | 0% | 0 | 0 / 0 |
breast | 6% | 18.95 | 27 / 459 | 13% | 0.80 | 146 / 1118 |
stomach | 1% | 2.79 | 5 / 359 | 15% | 0.64 | 43 / 286 |
eye | 0% | 0 | 0 / 0 | 16% | 0.40 | 13 / 80 |
intestine | 4% | 9.63 | 38 / 966 | 10% | 0.41 | 53 / 527 |
bladder | 0% | 0 | 0 / 21 | 12% | 0.56 | 58 / 504 |
adrenal gland | 7% | 40.33 | 18 / 258 | 3% | 0.11 | 7 / 230 |
spleen | 10% | 32.18 | 24 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.23 | 4 / 45 |
esophagus | 0% | 0.67 | 5 / 1445 | 6% | 0.20 | 11 / 183 |
adipose | 3% | 10.42 | 39 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 4.32 | 22 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 2.56 | 10 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.00 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006865 | Biological process | amino acid transport |
GO_0015718 | Biological process | monocarboxylic acid transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0031460 | Biological process | glycine betaine transport |
GO_0003333 | Biological process | amino acid transmembrane transport |
GO_0051936 | Biological process | gamma-aminobutyric acid reuptake |
GO_0015812 | Biological process | gamma-aminobutyric acid transport |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0042995 | Cellular component | cell projection |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0015171 | Molecular function | amino acid transmembrane transporter activity |
GO_0008028 | Molecular function | monocarboxylic acid transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0005332 | Molecular function | gamma-aminobutyric acid:sodium:chloride symporter activity |
Gene name | SLC6A12 |
Protein name | Transporter Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12) Solute carrier family 6 member 12 |
Synonyms | BGT1 |
Description | FUNCTION: Transporter that mediates cellular uptake of betaine and GABA in a sodium- and chloride-dependent process . May have a role in regulation of GABAergic transmission in the brain through the reuptake of GABA into presynaptic terminals, as well as in osmotic regulation. Probably also involved in renal and hepatic osmotic regulation (By similarity). . |
Accessions | ENST00000684302.1 ENST00000535347.5 ENST00000537793.1 F5H4L6 ENST00000424061.6 P48065 ENST00000536824.5 F5H2T6 ENST00000397296.6 ENST00000359674.8 |